BioSpace News Archive

Adaptimmune Announces 70% of People with Advanced Synovial Sarcoma Who Respond to Afami-cel are Alive Two Years Post-Treatment; Data from Cohort 1 of SPEARHEAD-1 to be Presented at ASCO

Approximately 39% of patients had clinical responses after a single dose of afami-cel in Cohort 1 of the pivotal SPEARHEAD-1 trial and the median duration of response was ~12 months (CTOS 2022)

May 25, 2023
·
5 min read
BioMidwest

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development Acceleration with Endpoints for ASCO 2023

Novotech, the leading Asia Pacific centred biotech CRO is sponsoring key oncology focussed expert events for ASCO: a pre-ASCO Summit with eChina Health, and a webinar panel discussion on accelerating development of advanced therapies with Endpoints.

May 25, 2023
·
3 min read
Biotech Beach

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Aadi Bioscience, Inc. announced poster presentations at the 2023 ASCO Annual Meeting taking place June 2-6, 2023, in Chicago, IL.

May 25, 2023
·
3 min read
Drug Development

Zentalis Announces Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy at the 2023 ASCO Annual Meeting

Zentalis® Pharmaceuticals, Inc. announced positive data from the Phase 1b trial of azenosertib, the Company’s potentially first-in-class WEE1 inhibitor, in combination with chemotherapy in patients with platinum-resistant ovarian cancer.

May 25, 2023
·
10 min read
Drug Development

Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract

Oncolytics Biotech® Inc. announced positive results from BRACELET-1, a randomized phase 2 trial in HR+/HER2- metastatic breast cancer.

May 25, 2023
·
10 min read
Dizal’s Oncology Pipeline Continues to Impress with Two Oral Presentations at 2023 ASCO Annual Meeting

Dizal announced that data from its oncology portfolio will be presented at the 2023 American Society of Clinical Oncology Annual Meeting, June 2-6, 2023 in Chicago.

May 25, 2023
·
7 min read
Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine

Daewoong Pharmaceutical announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for idiopathic pulmonary fibrosis was published in EMBO Molecular Medicine on the 21st.

May 25, 2023
·
5 min read
Business

Invitae Announces CFO Transition and Selection of Veteran Finance Executive Christine Gorjanc as Interim CFO

Invitae, a leading medical genetics company, announced that Chief Financial Officer Yafei Wen is resigning to pursue other opportunities, effective June 30, 2023.

May 25, 2023
·
3 min read
Biotech Bay

CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Day One Biopharmaceuticals announced the publication of three abstracts on the American Society of Clinical Oncology website.

May 25, 2023
·
7 min read
Antengene To Present Latest Results from TORCH-2 Study of ATG-008 in Advanced Solid Tumors in Poster Discussion at ASCO 2023

Antengene Corporation Limited announced that the latest results from the Phase I/II TORCH-2 study will be presented as a poster at the 2023 American Society for Clinical Oncology Annual Meeting taking place from June 2nd to 6th, 2023 at the McCormick Place Convention Center in Chicago, IL.

May 25, 2023
·
6 min read